Remove Books Remove Packaging Remove Production
article thumbnail

Helping Knowledge Workers Be More Productive

Perficient: Drug Development

The term “knowledge worker” was first coined by Peter Drucker in his book, The Landmarks of Tomorrow ( 1959). Drucker defined knowledge workers as high-level workers who analyze data and apply theoretical/analytical knowledge to develop insights, trends, products, and services.

article thumbnail

How AI and LLMs are transforming drug discovery: part 1

Drug Target Review

This isnt about hype or grand promises its about identifying low-hanging fruit and achievable productivity gains. Recently, we’ve been pursuing AI product initiatives that have made me consider why people might be resistant to AI tools, what AI tools are capable of in drug discovery, and their limitations.

Drugs 69
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

FDA Issues “Cliffs Notes”-style Guidance on Cell and Gene Therapy; What Questions Did They Answer? (Part 1)

FDA Law Blog: Drug Discovery

Valentine On November 19, 2024, FDA released a draft guidance titled Frequently Asked Questions Developing Potential Cellular and Gene Therapy Products. However, as your high-school literature teacher warned youto ace the test, you need to read the book, ahem, source regulations, guidance, or other policy documents.

article thumbnail

Announcing Homeworld Ideas: A Writing Challenge

Codon

A good idea — presented clearly, backed by evidence, and packaged in a story — can help you raise money for a cause, rally people to an idea, or shift the directions of a field. Anyone can submit a piece in just about any format – poetry, essays, reportage, science fiction, book chapters, and so on.

article thumbnail

Article FDA Thank You FDA finalizes guidance on electronic submissions for OTC products

Agency IQ

FDA finalizes guidance on electronic submissions for OTC products FDA has fulfilled its commitment under the Over-the-Counter Monograph Drug User Fee (OMUFA) program to issue final guidance on how sponsors can electronically submit monographs and other documents. These products are regulated differently from traditional prescription drugs.

FDA 40
article thumbnail

Keeping tabs on Covid-19: Cell and gene clinical trials advance despite Covid-19…

The Pharma Data

Most importantly, we are continuing to see patients benefit from the profound therapeutic effects of both approved products and those currently in clinical development. CluePoints provides clinical studies with risk management support package during Covid-19. Download the e-book here. Source link.

article thumbnail

Release of ChEMBL 33

The ChEMBL-og

This fresh release comes with a few new data soures and also some new features: we added bioactivity data for understudied SLC targets from the RESOLUTE project and included a flag for Natural Products and for Chemical Probes. An an annotation for the ACTION_TYPE of a measurement was included for approx. 270 K bioactivities.